Clinical trials are an important part of the process of testing new medications and treatments to see if they are safe and effective. All medical treatments and devices must be tested with human subjects before they are approved by the FDA and made available for use. Because myositis diseases are rare, it’s sometimes hard for…
Continue Reading
The Myositis Association recognizes that the myositis patient’s best hope for a cure lies in research. TMA offers a research fellowship program to attract and encourage post-doctoral trainees (PhD and MD) and young physicians to pursue careers in the field of myositis research. TMA also funds research grants to initiate innovative pilot projects that will…
Continue Reading
Today, Kezar Life Sciences announced topline results from the PRESIDIO study, evaluating the efficacy and safety of zetomipzomib in dermatomyositis and polymyositis. In this study, most patients experienced a clinically meaningful improvement however, zetomipzomib did not demonstrate a significant differentiation from the placebo. We will learn more from this study with additional deeper analysis in…
Continue Reading